MD FINANCIAL STATEMENTS

Mednax Inc — balance sheet, income statement and cash flow trends

MDMednax Inc

🇺🇸 USA · NYSE · Healthcare · Medical Care Facilities

Value it Duel

Income Statement

Quarterly progression — trailing-twelve-month values

RevenueNet Income

Profit Funnel

Q1 2026 · TTM

Percentages are relative to revenue.

Key Figures

YoY change

Revenue1.9 B $-2.3%

Gross Profit498.4 M $+7.9%

Operating Income229.2 M $—

EBITDA279 M $—

Net Income174.2 M $—

Peer Comparison· Medical Care Facilities

Company	Rev. Growth	Gross Margin	EBITDA Margin	Net Margin
MD	-2.3%	25.8%	14.4%	9.0%
MPARK	13.0%	28.1%	27.7%	10.1%
SIA	16.7%	15.2%	17.2%	4.3%
REG	14.2%	11.2%	13.5%	3.0%
SNZ	13.3%	42.8%	47.9%	72.0%
RYM	215.1%	-5.9%	-21.8%	-60.1%
Industry median	10.2%	27.7%	13.8%	3.7%

Company	Rev. Growth	Gross Margin	EBITDA Margin	Net Margin
MD	-2.3%	25.8%	14.4%	9.0%
SGRY	5.4%	21.7%	28.7%	-2.3%
ASTH	56.7%	9.3%	4.6%	0.9%
SEM	29.2%	10.6%	9.4%	2.4%
AVAH	20.5%	32.7%	11.9%	10.4%
ADUS	19.6%	32.5%	11.1%	6.9%
Industry median	10.2%	27.7%	13.8%	3.7%

Balance Sheet

Quarterly period-end values

Total AssetsTotal LiabilitiesEquity

Capital Structure

Q1 2026

Equity878.6 M $42%
Current Liabilities442.6 M $21%
Long-term Liabilities749.1 M $36%

Key Figures

YoY change

Total Assets2.1 B $+3.9%

Total Liabilities1.2 B $-1.0%

Total Equity878.6 M $+11.3%

Cash & ST Investments329 M $+50.1%

Total Debt629.7 M $-3.9%

Net Debt423.9 M $-23.8%

Peer Comparison· Medical Care Facilities

Company	Current Ratio	Debt/Equity	NetDebt/EBITDA	Equity/Assets
MD	1.33	71.7%	1.08	42.4%
MPARK	1.19	50.0%	0.92	46.9%
SIA	0.60	165.1%	6.97	32.1%
REG	0.09	-26.7%	-1.12	-1.2%
SNZ	0.34	59.6%	11.44	36.0%
RYM	0.55	39.0%	-6.24	33.2%
Industry median	1.26	59.9%	1.87	35.7%

Company	Current Ratio	Debt/Equity	NetDebt/EBITDA	Equity/Assets
MD	1.33	71.7%	1.08	42.4%
SGRY	1.86	238.6%	4.01	21.0%
ASTH	1.35	133.1%	3.60	33.9%
SEM	1.15	170.3%	5.72	29.1%
AVAH	1.47	625.8%	4.39	11.9%
ADUS	1.83	12.4%	0.22	77.7%
Industry median	1.26	59.9%	1.87	35.7%

Cash Flow Statement

Quarterly progression — trailing-twelve-month values

Operating Cash FlowCapital ExpendituresFree Cash Flow

Cash Flow Bridge

Q1 2026 · TTM

Key Figures

YoY change

Operating Cash Flow259.1 M $+20.9%

Capital Expenditures21.4 M $+6.9%

Free Cash Flow237.7 M $+22.3%

Dividends Paid——

Peer Comparison· Medical Care Facilities

Company	CF Margin	FCF Margin	CapEx Ratio	CF/Net Income
MD	13.4%	12.3%	1.1%	148.7%
MPARK	17.8%	-1.7%	14.8%	175.9%
SIA	13.6%	1.2%	12.4%	312.7%
REG	31.0%	18.6%	12.4%	1,023.5%
SNZ	137.8%	87.4%	50.4%	191.5%
RYM	36.5%	31.3%	5.2%	-60.7%
Industry median	10.4%	5.8%	3.6%	165.7%

Company	CF Margin	FCF Margin	CapEx Ratio	CF/Net Income
MD	13.4%	12.3%	1.1%	148.7%
SGRY	8.4%	6.2%	2.2%	-367.9%
ASTH	4.7%	4.4%	0.3%	549.2%
SEM	6.3%	2.1%	4.2%	259.5%
AVAH	5.5%	5.4%	0.5%	53.1%
ADUS	10.0%	9.5%	0.5%	145.3%
Industry median	10.4%	5.8%	3.6%	165.7%

Amounts are in the company’s reporting currency. Peer comparison tables use ratio-based metrics so currency differences do not distort the picture.

Go deeper on MD

Run a DCF valuation

Full DCF model with editable assumptions

Start a head-to-head duel

Compare two stocks metric by metric

Filter in the stock screener

Build your own universe with 400+ metrics

Data on this page refreshes once per day. Price data as of Jul 6, 26. This content is for informational purposes only and is not investment advice.